Entities / Company
Geron Corporation.
company
- Reports this week
- 1
- Active events
- 1
- Connections
- 28
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
One to three months ago
Gone quiet
No new reports in 90+ days-
FDA approval fueled a stock price surge for Geron Corporation.Some support1 report
-
Geron Corporation stock traded on the Nasdaq exchange on July 1, 2026.Some support2 reports
-
Geron Corporation's product received regulatory approval in the European Union on June 1, 2026.Some support1 report
-
Harout Semerjian is appointed CEO of Geron Corporation, while Immunomedics is acquired by Gilead.Some support1 report
-
Geron Corporation granted stock options to Harout Semerjian upon his acceptance of employment on August 9, 2025.Some support4 reports
-
Semerjian worked at Novartis for 17 years.Some support1 report
-
Barclays maintained a Buy rating on Geron Corporation, noting that the company could benefit from Trump-era tariffs.Some support3 reports
-
James Ziegler purchased shares of Geron Corporation on September 1, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Geron Corporation this week
News at the entities that move Geron Corporation most-
FDA StructuralThe FDA approved Miplyffa for the treatment of Niemann-Pick disease.Moves Geron Corporation
-
Donald Trump Shared contextNPR investigated a detention plan implemented by the Trump administration, involving DHS policy officials.Moves Geron Corporation
-
Nasdaq StructuralAn AI stock sell-off impacted Nasdaq on November 5, 2026, following the election results.Moves Geron Corporation
-
Renaissance Technologies TransactionalRenaissance Technologies boosted its stake in the Direxion Daily FTSE China Bear 3X ETF, which was designed using a China Index created by Bank of New York.Moves Geron Corporation
-
LinkedIn Mentioned togetherNextPlat Corp connected with users on social media on August 6, 2025.Moves Geron Corporation
-
American Society of Hematology Shared contextAscentage Pharma Group International presented research data at the ASH Annual Meeting in New Orleans.Moves Geron Corporation
Connections
The 7 strongest of 28, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
Geron Corporation is publicly listed and trades on the Nasdaq stock exchange, relying on its infrastructure for market presence.
-
FDA Structural
Geron Corporation is subject to the regulatory oversight and approval processes of the FDA.
-
Renaissance Technologies Transactional
Renaissance Technologies boosted its stock stake in Geron Corporation.
-
Donald Trump Shared context
Geron Corporation's stock benefits are predicted to be linked to potential financial effects of Trump-era tariffs.
-
LinkedIn Mentioned together
The entities are co-mentioned in the context of investor relations and updates.
-
American Society of Hematology Shared context
Geron Corporation presents scientific data at the American Society of Hematology meeting.
-
Goldman Sachs Transactional
Geron Corporation management attended a conference hosted by Goldman Sachs.
History
Events by the month they beganNovember 2026
1 eventAugust 2026
1 eventShow 1 earlier month
June 2026
7 events- Geron Corporation's product was approved in the United States and the company was listed on Nasdaq on August 19, 2025.
- Geron Corporation's product received regulatory approval in the European Union on June 1, 2026.
- Harout Semerjian is appointed CEO of Geron Corporation, while Immunomedics is acquired by Gilead.
- Geron Corporation granted stock options to Harout Semerjian upon his acceptance of employment on August 9, 2025.
- Semerjian worked at Novartis for 17 years.
- Barclays maintained a Buy rating on Geron Corporation, noting that the company could benefit from Trump-era tariffs.
- James Ziegler purchased shares of Geron Corporation on September 1, 2025.